5/25/2005 8:42:38 AM ET


    LARGE U.S. NATIONAL PHARMACY CHAIN PURCHASE ORDER FOR O24™ PAIN NEUTRALIZER PRODUCT
    BOOSTS TOTAL STORE COUNT ABOVE 13,000 LEVEL
      
    FOR IMMEDIATE RELEASE

    Stock Symbol: OTC BB: SWME
    May 25, 2005

    LARGE U.S. NATIONAL PHARMACY CHAIN PURCHASE ORDER FOR O24™ PAIN NEUTRALIZER PRODUCT
    BOOSTS TOTAL STORE COUNT ABOVE 13,000 LEVEL

    Toronto, Canada – Swiss Medica, Inc. (OTC BB: SWME), is pleased to announce that purchase orders from a
    large U.S. national pharmacy chain and a dominant U.S. regional pharmacy chain have increased coverage for
    the O24™ Pain Neutralizer product to more than 13,000 stores, nearly 70 percent of which are in the United
    States.

    “We are delighted that excitement is growing for our flagship, patented O24™ Pain Relief product,” said Tom
    Quinn, Swiss Medica’s Executive Vice President. “We surpassed our store guidance for Q2, sales are
    approaching US$1 million for the first half of Q2 (April 1 to May 20), and year-to-date sales have surpassed
    US$2 million. O24™ product has been shipped to the national U.S. pharmacy chain and will be available in June
    2005 for the first time in major markets such as New England, the Carolinas, Texas, and Florida.”


    About Swiss Medica Inc.

    Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
    market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a
    world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
    visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.

    Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain
    relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by
    healthcare professionals in the United States, Canada and in Europe. O24™ is widely available throughout
    Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of
    pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and
    store locators for the nearest pharmacy.

    Swiss Medica also manufactures PMS Escape® which holds US Patent #’s 5760014 and 5612320. PMS
    Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce
    changes in mood and appetite that women experience during the premenstrual period. Customers can also visit
    www.pmsescape.com for additional information and ordering details.


    Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United
    States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
    statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
    transactions being contemplated, risks related to international sales and potential foreign currency exchange
    fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological
    changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's
    periodic reports filed with the United States Securities and Exchange Commission and other regulatory
    authorities.

    For more information, please contact:

    Swiss Medica Inc.
    Investor Relations Contact:
    David Jones
    866) 485-4243
    djones@swissmedica.com